ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Elderly Patients Fail To Receive New Cancer Therapy For CML

August 27, 2010

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990

Research Opportunities In Pancreas Cancer Described; Top Priority Set

December 21, 1973

Foundation offers funds for mesothelioma research.

July 9, 2004

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

July 18, 1986

RFAs In Bladder, Prostate, Ok’d By DCBDC Advisors

March 1, 1991